Chinese firm all ready for mass vaccine production


Engineers work on an experimental vaccine for the Covid-19 coronavirus at the Quality Control Laboratory at the Sinovac Biotech facilities in Beijing on April 29, 2020. - AFP

BEIJING (AFP): A researcher in a lab coat in Beijing holds up the hopes of humanity in his fingers: "Coronavac", an experimental vaccine against the coronavirus that has upended the world.

Sinovac Biotech, which is conducting one of the four clinical trials that have been authorised in China, has claimed great progress in its research and promising results among monkeys.

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
China , vaccine , mass , production , Sinovac , ready , trials

Next In Regional

China AI robot restaurant analyses diners’ faces, tongues to recommend health-focused dishes
Why China’s humanoid robots are still waiting for their ‘ChatGPT moment’
Singapore turns tide in evolving fight against scams
Africa emerges as new arena in US-China competition over artificial intelligence
China’s parents are outsourcing the homework grind to AI
Where are China’s AI doomers?
China's overstretched healthcare looks to AI boom
Smaller, faster, smarter: Chinese transistor ready for future AI chips
Jimmy Lai to be sentenced on Monday in Hong Kong national security trial
Chinese AI firms defend safety practices, push back on Western criticism

Others Also Read